Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.97% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Technology | 12.95% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Antero Resources
AR
$10.9B
| $46.5M | 0.04% |
1,355,461
+130,001
| +11% | +$5.16M |
|
352
Viavi Solutions
VIAV
$7.95B
| $46.3M | 0.04% |
7,036,465
-44,260
| -0.6% | -$323K |
|
|
FLXN
353
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $45.9M | 0.04% |
2,095,007
+91,594
| +5% | +$1.85M |
|
354
Wayfair
W
$11.8B
| $45.5M | 0.04% |
1,209,888
-115,039
| -9% | -$3.72M |
|
355
Packaging Corp of America
PKG
$22.2B
| $45.2M | 0.04% |
723,961
+4,082
| +0.6% | +$287K |
|
356
NRG Energy
NRG
$26.2B
| $45.1M | 0.04% |
1,971,277
-4,663,237
| -70% | -$116M |
|
|
LPNT
357
DELISTED
LifePoint Health, Inc.
LPNT
| $44.6M | 0.04% |
513,278
+159,663
| +45% | +$12.1M |
|
|
JNPR
358
DELISTED
Juniper Networks
JNPR
| $44.6M | 0.04% |
1,718,304
-598,528
| -26% | -$15.7M |
|
359
Moelis & Co
MC
$4.85B
| $44.6M | 0.04% |
1,553,866
+46,133
| +3% | +$1.35M |
|
|
VR
360
DELISTED
Validus Hold Ltd
VR
| $44.5M | 0.04% |
1,010,950
+24,957
| +3% | +$1.07M |
|
|
TW
361
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $44.4M | 0.04% |
352,568
-929,523
| -73% | -$125M |
|
|
MXIM
362
DELISTED
Maxim Integrated Products
MXIM
| $44.2M | 0.04% |
1,279,451
+169,932
| +15% | +$5.81M |
|
|
RYL
363
DELISTED
RYLAND GROUP INC
RYL
| $44M | 0.04% |
+948,555
| New | +$42.1M |
|
364
NCR Voyix
VYX
$1.19B
| $43.6M | 0.04% |
2,363,288
-1,076,832
| -31% | -$19.9M |
|
365
MACOM Technology Solutions
MTSI
$17.4B
| $43M | 0.04% |
1,125,186
+1,067,092
| +1,837% | +$39.4M |
|
366
Larimar Therapeutics
LRMR
$377M
| $42.9M | 0.04% |
103,256
+23,788
| +30% | +$9.95M |
|
367
Pembina Pipeline
PBA
$29.3B
| $42.7M | 0.04% |
1,323,103
+4,372
| +0.3% | +$146K |
|
368
General Motors
GM
$80.9B
| $42.4M | 0.04% |
1,272,830
-959,403
| -43% | -$34.2M |
|
369
Coca-Cola
KO
$383B
| $41.8M | 0.04% |
1,066,636
-495,741
| -32% | -$20.2M |
|
370
Neurocrine Biosciences
NBIX
$18.2B
| $41.8M | 0.04% |
875,731
+6,063
| +0.7% | +$257K |
|
|
DM
371
DELISTED
Dominion Energy Midstream Ptr LP
DM
| $41.5M | 0.04% |
1,083,013
+3,216
| +0.3% | +$130K |
|
|
XIFR
372
XPLR Infrastructure LP
XIFR
$1.04B
| $41.4M | 0.04% |
1,045,403
+197,519
| +23% | +$8.56M |
|
|
AM
373
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
| $41.4M | 0.04% |
1,444,638
-105,973
| -7% | -$2.85M |
|
|
SUM
374
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $41.1M | 0.04% |
1,709,068
+1,081,047
| +172% | +$25.7M |
|
|
CHS
375
DELISTED
Chicos FAS, Inc.
CHS
| $41M | 0.04% |
2,466,978
+109,863
| +5% | +$1.87M |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.